Article Text
DTB select
Safety update: hyoscine hydrobromide patches and serious anticholinergic adverse effects
Abstract
Overview of: Medicines and Healthcare products Regulatory Agency. Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia. Drug Safety Update 2023;16:1.
- Drug-Related Side Effects and Adverse Reactions
- Health Care Quality, Access, and Evaluation
Statistics from Altmetric.com
Footnotes
Contributors DTB Team.
Provenance and peer review Commissioned; internally peer reviewed.